PAA 2.50% 20.5¢ pharmaust limited

Ann: Demonstration batch of smaller size MPL tablets completed, page-9

  1. 853 Posts.
    lightbulb Created with Sketch. 293
    Hahaha....

    It started off as a cancer drug in dogs and Elanco didn’t want a piece of it but PAA continued to purse this area. Perhaps they think they are smarter than Elanco.

    Then they switched to MND and Covid. Both very topical diseases. Covid was screened at WEHI but that went nowhere so they took it overseas. If it was any good it would have stayed in Australia. WEHI is Australia’s leading research facility.

    Good luck but I feel there’s are few darts being thrown atm.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.